SCHEMBL30622575

SCHEMBL30622575

Cc1cc2c(Br)cccc2n1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.46
ALKBH5 Q6P6C2 1/20 0.44
FTO Q9C0B1 1/20 0.44
KDM4E B2RXH2 4/20 0.43
NQO2 P16083 1/20 0.43
HSD17B10 Q99714 4/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
MAPT P10636 2/20 0.39
ACHE P22303 1/20 0.39
DHFR P00374 1/20 0.38
JAK2 O60674 1/20 0.38
BTK Q06187 1/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
HTT P42858 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18000262 1.00 GPR3 (0.46) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL27769612 0.90 KDM4E (0.40) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL24136214 0.82 ALDH1A1 (0.32) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL13548554 0.79 ALKBH5 (0.52) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL21432468 0.78 GPR3 (0.45) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL30480838 0.78 KDM4E (0.50) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL26547562 0.78 KDM4E (0.50) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL19643772 0.77 DHFR (0.43) CASP1CASP7CYP2C19CYP1A2CYP3A4
SCHEMBL1355293 0.76 DHFR (0.45) GPR3ALKBH5FTOKDM4ENQO2
SCHEMBL18000203 0.76 GPR3 (0.41) GPR3ALKBH5FTOKDM4ENQO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS VANDERBILT UNIVERSITY 2023-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230330099-A1 SUBSTITUTED INDOLE MCL-1 INHIBITORS MCL1, BCL2L1, BCL9 GPR3 3611/4885ALKBH5 3013/4885FTO 4687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.